Atrazine and Metolachlor: Impacts on Ovulation and Pregnancy – An Expanded Academic and Policy Perspective


Abstract

Atrazine and metolachlor, two of the most frequently applied herbicides in global agriculture, have emerged as major environmental and reproductive health concerns. Used extensively in cereal and sugarcane production, their persistence in soil, air, and water systems results in chronic exposure among farming communities—particularly women of reproductive age. Accumulating evidence demonstrates that these chemicals act as endocrine disruptors capable of altering ovulation, menstrual regularity, and pregnancy outcomes. This paper presents an expanded interdisciplinary analysis of their mechanisms of toxicity, epidemiological findings, and policy implications. It emphasizes the vulnerabilities of women in low- and middle-income countries (LMICs), where regulation and protective measures are weak, and concludes with actionable policy recommendations for safer agricultural transitions.


1. Introduction

The intensification of agriculture in developing economies has increased reliance on herbicides such as atrazine and metolachlor. Both belong to classes of pre-emergent herbicides that prevent weed germination and enhance crop yields. However, their chemical stability and water solubility lead to widespread environmental persistence.

Atrazine, a triazine derivative, and metolachlor, an acetanilide compound, are among the most frequently detected herbicide residues in groundwater, surface water, and food crops worldwide. Studies in Kenya, Uganda, Ghana, and South Africa reveal atrazine concentrations in surface waters exceeding WHO’s recommended limit of 2 µg/L in several agricultural basins (Njuguna et al., 2023). Similarly, metolachlor residues have been identified in vegetables and sediments in West African irrigation zones.

For women—especially farmworkers and those living near treated fields—exposure occurs through inhalation of spray drift, ingestion of contaminated water, and dermal absorption during planting and weeding. The timing of exposure is critical: exposure during ovulation or early pregnancy can disrupt hormonal balance and embryonic development. Despite mounting scientific evidence, both herbicides remain legal and widely used across Africa, Asia, and Latin America.


2. Mechanisms of Endocrine and Reproductive Disruption

2.1 Atrazine and the Hypothalamic-Pituitary-Gonadal (HPG) Axis

Atrazine acts primarily as an endocrine-disrupting compound (EDC). Laboratory and epidemiological studies show that it interferes with the hypothalamic-pituitary-gonadal axis—the system that regulates sex hormone production. Atrazine increases aromatase enzyme expression, leading to excessive conversion of androgens to estrogens. The resulting estrogen dominance suppresses the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), key regulators of ovulation.

Disruption of this axis manifests as:

  • Irregular or anovulatory menstrual cycles

  • Altered follicular maturation

  • Decreased progesterone synthesis

  • Infertility and early pregnancy loss

Animal studies have confirmed these outcomes. In rodent models, chronic low-dose atrazine exposure (0.5–10 mg/kg/day) reduced ovary size, delayed ovulation, and caused luteal insufficiency (Hayes et al., 2022).

2.2 Metolachlor and Oxidative Stress in Ovarian Tissue

Metolachlor exerts its reproductive toxicity mainly through oxidative stress and mitochondrial dysfunction. It generates reactive oxygen species (ROS) that damage ovarian granulosa cells—the cells responsible for estrogen and progesterone production. This results in:

  • Depletion of ovarian follicles

  • Disruption of oocyte maturation

  • Decreased steroid hormone levels

  • Increased apoptotic (cell death) activity in ovarian tissue

Moreover, metolachlor and its metabolites can cross the placental barrier, leading to embryotoxicity. Studies show placental structural changes, reduced fetal weight, and increased rates of fetal resorption in rats exposed to metolachlor (Kim et al., 2021).


3. Impacts on Ovulation and Pregnancy

3.1 Ovulatory Dysfunction

Women exposed to atrazine-contaminated water often show altered levels of estradiol, progesterone, and prolactin. Epidemiological studies in the U.S. Midwest agricultural belt found associations between elevated urinary atrazine metabolites and menstrual irregularities and delayed ovulation (Cragin et al., 2019). Similar findings are emerging from African studies, suggesting subfertility among women residing in high-herbicide-use areas.

Metolachlor compounds the risk by damaging ovarian follicles, reducing oocyte quality, and altering the hormonal milieu required for ovulation. Chronic exposure thus leads to lower conception rates and increased infertility risk.

3.2 Adverse Pregnancy Outcomes

Both atrazine and metolachlor are linked to adverse pregnancy outcomes. Atrazine exposure during early gestation is associated with:

  • Spontaneous abortion

  • Preterm birth

  • Low birth weight

  • Congenital anomalies (including orofacial and limb malformations)

A multi-country meta-analysis (Zhao et al., 2023) found that maternal atrazine exposure increased miscarriage risk by 30–40%, with effects most pronounced in agricultural regions. Metolachlor, though less extensively studied in humans, has shown embryotoxicity and placental dysfunction in animal models.

3.3 Epigenetic and Transgenerational Effects

Emerging research highlights that these herbicides can induce heritable changes in gene expression without altering DNA sequences—a phenomenon known as epigenetic modification. Atrazine has been shown to alter DNA methylation of genes controlling folliculogenesis and hormone signaling. These epigenetic marks can be passed to offspring, resulting in transgenerational fertility impairment even when subsequent generations are not directly exposed (Skinner et al., 2022).


4. Women’s Vulnerability and Socioeconomic Context

Women in LMICs are uniquely vulnerable due to:

  • Occupational exposure: Many women participate directly in planting, weeding, and harvesting, often barefoot and without gloves or masks.

  • Domestic exposure: Contaminated water used for cooking and cleaning increases ingestion risks.

  • Physiological susceptibility: Women’s higher body fat content facilitates greater storage of lipophilic compounds like atrazine.

  • Pregnancy vulnerability: The developing fetus is particularly sensitive to hormonal disruption.

In Kenya and Ghana, studies have detected atrazine in breast milk and umbilical cord blood, indicating maternal-fetal transfer (Eboh et al., 2024). Moreover, limited access to healthcare and occupational safety training exacerbates the health impacts.


5. Policy and Regulatory Gaps

5.1 Weak Regulation and Enforcement

While the European Union banned atrazine in 2004, citing persistent groundwater contamination, it remains approved in much of sub-Saharan Africa. Metolachlor continues to be sold under multiple formulations, often without adequate risk communication or protective guidelines.

Many LMICs face challenges such as:

  • Absence of toxicological monitoring programs for pesticide residues in water and human tissues.

  • Lax enforcement of pesticide import and use regulations.

  • Limited health surveillance of exposed populations.

  • Gender-insensitive agricultural policies that overlook women’s occupational health risks.

5.2 Data Deficiency and Research Gaps

There is minimal reproductive health research on women in African agricultural contexts. Most data on herbicide exposure originate from high-income countries, limiting the applicability of risk assessments to African settings.


6. Policy Recommendations

  1. Regulatory Reform and Phase-Out:

    • Adopt precautionary bans or phase-outs of atrazine and metolachlor, as done in the EU.

    • Revise national pesticide lists under the Rotterdam and Stockholm Conventions to include these chemicals.

  2. Environmental and Biological Monitoring:

    • Establish pesticide residue monitoring programs in water, soil, and food.

    • Implement biomonitoring for women of reproductive age using urine or breast milk assays.

  3. Gender-Responsive Agricultural Policy:

    • Integrate gender analysis into pesticide regulation and agricultural health training.

    • Provide PPE and safe handling training specifically targeting female farmers.

  4. Promotion of Safer Alternatives:

    • Encourage integrated weed management (IWM) strategies—crop rotation, mulching, and biological control.

    • Support organic and low-input farming initiatives through agricultural subsidies and technical assistance.

  5. Health System Strengthening:

    • Train healthcare providers to recognize and manage pesticide-related reproductive disorders.

    • Establish reproductive health screening for women in high-exposure regions.

  6. Community Awareness and Education:

    • Use public health campaigns to inform women about herbicide hazards, safe practices, and early signs of toxicity.

    • Engage local leaders, cooperatives, and NGOs to promote behavior change at community level.


7. Conclusion

Atrazine and metolachlor represent a silent but significant threat to female reproductive health. Their capacity to interfere with ovulation, alter hormone balance, and compromise pregnancy outcomes underscores the urgent need for regulatory action. The risks extend beyond individuals—transgenerational epigenetic effects suggest that today’s exposure could affect the fertility of future generations.

Policy must therefore shift from reactive control toward preventive protection, emphasizing sustainable agricultural practices, environmental monitoring, and women-centered health governance. Protecting women from the reproductive toxicity of herbicides is both a public health priority and a moral obligation within sustainable development frameworks.


References

  • Cragin, L. A., et al. (2019). Female reproductive health and herbicide exposure: Evidence from the U.S. Midwest. Environmental Health, 18(1), 42.

  • Eboh, R., Owusu, F., & Mwakio, P. (2024). Herbicide residues and reproductive health among smallholder women farmers in sub-Saharan Africa. Journal of Environmental Science and Health, Part B, 59(2), 145–158.

  • Hayes, T. B., et al. (2022). Atrazine-induced endocrine disruption: Mechanisms and outcomes. Environmental Health Perspectives, 130(4), 046002.

  • Kim, H. S., et al. (2021). Metolachlor-induced oxidative stress and reproductive toxicity in rats. Toxicology Reports, 8, 876–885.

  • Njuguna, A., et al. (2023). Pesticide residues in Kenyan river systems and implications for reproductive health. African Journal of Environmental Health Sciences, 10(3), 189–204.

  • Skinner, M. K., et al. (2022). Transgenerational epigenetic effects of atrazine on reproduction. Reproductive Toxicology, 110, 87–99.

Comments

Popular posts from this blog